Thomas Bachelot - Concepedia

Author

Thomas Bachelot

Also Known As

Bachelot T., Bachelot, Thomas, Bachelot, Thomas Denis, Chua, Boon H., Georgia Chenevix-Trench, Lee, Soo-Chin, T Bachelot, T. Bachelot, T. D. Bachelot, Thomas BACHELOT

551

Publications

24.4K

Citations

H-Index

108

Concepts

All Affiliations

Centre Léon Bérard Institut Curie Inserm Institut Gustave Roussy Institut de Cancérologie de l'Ouest

About

Thomas Bachelot is an author at Centre Léon Bérard specializing in medicine, oncology, and breast cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	77	7.8K
2	Health Sciences	14	19	1.5K
3	Public Health	6	6	694
4	Engineering	1	1	24
5	Nursing	1	1	30

Thomas Bachelot

157

Publications

22K

Citations

H-Index

Page 1

	Year	Citations
Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer José Baselga, Mario Campone, Martine Piccart, New England Journal of Medicine	2011	2.8K
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer Gabriel N. Hortobágyi, Salomon M. Stemmer, Howard A. Burris, New England Journal of Medicine	2016	1.9K
Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer Rashmi K. Murthy, Sherene Loi, Alicia Okines, New England Journal of Medicine	2019	1.3K
Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas Isabelle Ray‐Coquard, Claire Cropet, M. van Glabbeke, Cancer Research	2009	780
Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study Thomas Bachelot, Gilles Romieu, Mario Campone, The Lancet Oncology Breast OncologyBrain MetastasesMedicineCancer ManagementPharmacology	2012	733
Regulatory T Cells Recruited through CCL22/CCR4 Are Selectively Activated in Lymphoid Infiltrates Surrounding Primary Breast Tumors and Lead to an Adverse Clinical Outcome Michael Gobert, Isabelle Treilleux, Nathalie Bendriss‐Vermare, Cancer Research	2009	731
Randomized Phase II Trial of Everolimus in Combination With Tamoxifen in Patients With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer With Prior Exposure to Aromatase Inhibitors: A GINECO Study Thomas Bachelot, C. Bourgier, Claire Cropet, Journal of Clinical Oncology	2012	707
Genomic characterization of metastatic breast cancers François Bertucci, Charlotte K.Y. Ng, Anne Patsouris, Nature Breast OncologyOncologyMedicineCancer GenomicsBreast Cancer	2019	706
EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours Émilie Le Rhun, Matthias Gückenberger, Marion Smits, Annals of Oncology Neuro-oncologySurgical OncologyTumoral PathologyMedicineSolid Tumours	2021	541
Dendritic Cell Infiltration and Prognosis of Early Stage Breast Cancer Isabelle Treilleux, Jean‐Yves Blay, Nathalie Bendriss‐Vermare, Clinical Cancer Research	2004	442

Page 1